Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2018-04-11
2020-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Large Series of Clinical and Imaging Investigation to Patients With Chronic Lower Limb Edema With Unclear Etiology
NCT01208623
Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
NCT01312220
Establishment of Vascular Permeability Model for Research Purpose by Human Umbilical Vascular Endothelial Cells
NCT01261195
Sublingual Microcirculation of Healthy Volunteers by Using the Third Generation Microcirculation Video Microscope
NCT02412839
Advanced Analysis of the Carotid Phonoangiography and Diseases
NCT02049463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients underwent supermicrosurgical LVA
Patients underwent supermicrosurgical LVA between June 2018 and May 2019.
pre-LVA
Venous serum samples were collected from patients before LVA.
post-LVA
Venous serum samples were collected from patients one-month after LVA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pre-LVA
Venous serum samples were collected from patients before LVA.
post-LVA
Venous serum samples were collected from patients one-month after LVA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral lower limb lymphedema
* lymphedema duration \> 2 years
* no active infection
* no prophylactic antibiotic use for at least one month before LVA
* no tumor recurrence or metastasis
* no consumption of antioxidants, such as vitamin E or ascorbic acid
Exclusion Criteria
20 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201800306B0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.